Professor Sumeet Mahajan
Co-founder & CEO
Dr George Devitt
Co-founder,
Scientific Director
George Devitt is an early-career Research Fellow at the University Hospital Southampton NHS Foundation Trust and the University of Southampton. His research is interdisciplinary and encompasses chemically- and structurally-sensitive spectroscopic and imaging methods to study neurodegenerative disease mechanisms, therapies, and biomarkers, with a focus on the translation of spectroscopic technologies for dementia diagnosis. He has published 10 papers and 2 patents. A recipient of Alzheimer's Reseach UK and EPSRC Business and Commercialisation fellowships, he is currently a Research and Innovation Associate on a UKRI Cross-Council award for developing and testing his new MX-Raman technology for dementia diagnosis.
Sumeet Mahajan is a Professor of Molecular Biophotonics and Imaging, the Deputy Head of the School in Chemistry and Academic Lead for Imaging in the Institute for Life Sciences at the University of Southampton. His group is highly interdisciplinary and researches label-free, non-invasive, chemically- & structurally-informative spectroscopic and imaging methods to study biological and environmental processes and develops technologies for early, faster and more sensitive detection, monitoring and health diagnostics. He has published >150 papers and 6 patents. A recipient of EPSRC and ERC fellowships, he currently co-leads an EPSRC Prosperity Partnership, an EPSRC Transformative Healthcare 2050 programme and a UKRI Cross-Council award for developing and testing his new MX-Raman technology for dementia diagnosis.
Professor Amrit Mudher
Biology Director
Amrit Mudher is a Professor of Neurosciences Southampton and the Associate Dean for Internationalisation for the Faculty of Environmental and Life Sciences at the University of Southampton. She has a long standing track record in establishing pre-clinical models of neurodegenerative disease and identify disease-modifying drug targets. More recently she has engaged in multiple inter-disciplinary collaborations to use knowledge of early mechanism of disease to inform sensitive and differential biomarkers of dementia. She sits on several national and international dementia forums including the Alzheimer’s Society Research and Strategy Group and the Alzheimer Association Scientific Panel. She has published nearly 100 papers and been the recipient of funding from Alzheimer’s charities, European Commission, NC3Rs and UKRI funding bodies.
Dr Simon Lane
VP Technology
Simon Lane is an interdisciplinary scientist and technologist with a background in physiology, cell biology, optics, and engineering. He focuses on technology innovation, designing advanced imaging and spectroscopy systems and custom devices that integrate biology with software, firmware, and hardware development. He has authored over 40 publications with almost 2000 citations, holds two patents, and is a researcher co-investigator on the TIQBio EPSRC Prosperity Partnership at the University of Southampton.
Team
.jpg)
Dr Mark Day
Scientific/Business Advisor
Mark J. Day served in many roles over his 18-year tenure at iRhythm Technologies (IRTC), most recently as Chief Technology Officer from 2022-2024, and previously as Executive Vice President of Research & Development from 2012-2022, a role that also held executive responsibility for Manufacturing, Regularly and Quality and Intellectual Property throughout iRhythm’s transition from startup to public company. Previous to joining iRhythm as a seven-employee startup in 2007, Mark worked in the Cardiac Rhythm Disease Management division of Medtronic, Inc. and, prior to that, was the Chief Technical Officer of CarePages, Inc., a blogging site for patients. In addition, Mark served as an independent board member for Circle Cardiovascular Imaging from 2016 through 2022. Mr. Day has a M.B.A. in Marketing from the Wharton School, University of Pennsylvania, a Ph.D. in Computation Flow Physics from Stanford University, and also received a M.S. from Stanford, and a B.Sc. from Queen’s University, both in Mechanical Engineering.
Callum Ellis
Buiness Development and Operation Manager
Callum Ellis is a final year PhD student working at the interface of computational chemistry and biophotonics looking at the aggrgeation mechanism of tau in Alzheimer's Disease. Prior to starting his studies and working with Brainalyze, he worked at Lilly for 6 years as part of the Commercial Graduate Leadership Programme, working across a range of commercial roles in a number of disease areas. Callum is leading on Brainalyze's work with the pharmaceutical industry, and provides operational support across the business.
Dr Simon Lane
VP Technology
Simon Lane is an interdisciplinary scientist and technologist with a background in physiology, cell biology, optics, and engineering. He focuses on technology innovation, designing advanced imaging and spectroscopy systems and custom devices that integrate biology with software, firmware, and hardware development. He has authored over 40 publications with almost 2000 citations, holds two patents, and is a researcher co-investigator on the TIQBio EPSRC Prosperity Partnership at the University of Southampton.
Professor Amrit Mudher
Biology Director
Amrit Mudher is a Professor of Neurosciences Southampton and the Associate Dean for Internationalisation for the Faculty of Environmental and Life Sciences at the University of Southampton. She has a long standing track record in establishing pre-clinical models of neurodegenerative disease and identify disease-modifying drug targets. More recently she has engaged in multiple inter-disciplinary collaborations to use knowledge of early mechanism of disease to inform sensitive and differential biomarkers of dementia. She sits on several national and international dementia forums including the Alzheimer’s Society Research and Strategy Group and the Alzheimer Association Scientific Panel. She has published nearly 100 papers and been the recipient of funding from Alzheimer’s charities, European Commission, NC3Rs and UKRI funding bodies.
Professor Sumeet Mahajan
Co-founder, CEO & CTO
Sumeet Mahajan is a Professor of Molecular Biophotonics and Imaging, the Deputy Head of the School in Chemistry and Academic Lead for Imaging in the Institute for Life Sciences at the University of Southampton. His group is highly interdisciplinary and researches label-free, non-invasive, chemically- & structurally-informative spectroscopic and imaging methods to study biological and environmental processes and develops technologies for early, faster and more sensitive detection, monitoring and health diagnostics. He has published >150 papers and 6 patents. A recipient of EPSRC and ERC fellowships, he currently co-leads an EPSRC Prosperity Partnership, an EPSRC Transformative Healthcare 2050 programme and a UKRI Cross-Council award for developing and testing his new MX-Raman technology for dementia diagnosis.
Dr George Devitt
Co-founder, Scientific Director
George Devitt is an early-career Research Fellow at the University Hospital Southampton NHS Foundation Trust and the University of Southampton. His research is interdisciplinary and encompasses chemically- and structurally-sensitive spectroscopic and imaging methods to study neurodegenerative disease mechanisms, therapies, and biomarkers, with a focus on the translation of spectroscopic technologies for dementia diagnosis. He has published 10 papers and 2 patents. A recipient of Alzheimer's Reseach UK and EPSRC Business and Commercialisation fellowships, he is currently a Research and Innovation Associate on a UKRI Cross-Council award for developing and testing his new MX-Raman technology for dementia diagnosis.